VIRGINIA BEACH, Va., Dec. 17 /PRNewswire-USNewswire/ -- According to recent statistics, LifeNet Health was able to distribute40,040 allograft bio-implants to patients in November 2009, an unprecedented number in LifeNet Health's 27-year history.
LifeNet Health saw a substantial increase in the number of bio-implants supplied to hospitals
"We are proud to serve patients around the world. These LifeNet Health allograft bio-implants provide restored mobility and an enhanced life. Our goal is to continue developing break-through technology and providing bio-implants that save lives and restore health," said Rony Thomas, LifeNet Health CEO and President.
Since 1995, LifeNet Health has distributed more than two million bio-implants with no incidence of disease transmission linked to tissue screened and processed using LifeNet Health's proprietary Allowash(R) technology. All allograft tissue undergoes a multi-step quality assurance review that exceeds the standards set by both the FDA and American Association of Tissue Banks (AATB).
LifeNet Health, a non-profit global leader in regenerative medicine, is the world's largest provider of bio-implants and organs for transplantation whose mission is saving lives and restoring health by advancing the field of tissue engineering.
For more information about LifeNet Health visit www.lifenethealth.org.
SOURCE LifeNet Health
Subscribe to our Free Newsletters!